Medikit Co.,Ltd.

Equities

7749

JP3921060004

Medical Equipment, Supplies & Distribution

Market Closed - Japan Exchange Other stock markets 01:15:51 2025-12-17 EST			5-day change	1st Jan Change
2,852.00 ^JPY	+0.39%		+0.74%	+5.55%

11-13	Medikit Co.,Ltd.'s Equity Buyback announced on November 12, 2025, has closed with 150,000 shares, representing 1.03% for ¥409.8 million.	CI
11-13	Tranche Update on Medikit Co.,Ltd.'s Equity Buyback Plan announced on November 12, 2025.	CI

Tranche Update on Medikit Co.,Ltd.'s Equity Buyback Plan announced on November 12, 2025.

Published on 11/13/2025 at 10:34 am EST

S&P Capital IQ

Medikit Co.,Ltd.

+0.39%

From November 12, 2025 to November 13, 2025, the company has repurchased 150,000 shares, representing 1.03% for ¥409.8 million. With this, the company has completed the repurchase of 150,000 shares, representing 1.03% for ¥409.8 million under the buyback announced on November 12, 2025.

Latest news about Medikit Co.,Ltd.

11-13	Medikit Co.,Ltd.'s Equity Buyback announced on November 12, 2025, has closed with 150,000 shares, representing 1.03% for ¥409.8 million.	CI
11-13	Tranche Update on Medikit Co.,Ltd.'s Equity Buyback Plan announced on November 12, 2025.	CI
11-11	Medikit Co.,Ltd. authorizes a Buyback Plan.	CI
11-11	Medikit Co.,Ltd. announces an Equity Buyback for 150,000 shares, representing 1.71% for ¥409.8 million.	CI
03-31	Medikit Co.,Ltd. agreed to acquire Antileak Business of KOBAYASHI & CO.,LTD. from Kobayashi & Co., Ltd.	CI
03-05	Tranche Update on Medikit Co.,Ltd.'s Equity Buyback Plan announced on November 11, 2024.	CI
02-27	Medikit Co.,Ltd.'s Equity Buyback announced on November 11, 2024, has closed with 193,700 shares, representing 1.31% for ¥549.66 million.	CI
01-07	Tranche Update on Medikit Co.,Ltd.'s Equity Buyback Plan announced on November 11, 2024.	CI
12-02	Inari Medical, Inc. Enters into A Distribution Agreement with Medikit Co., Ltd	CI
11-11	Medikit Co.,Ltd. announces an Equity Buyback for 250,000 shares, representing 1.69% for ¥711.75 million.	CI
11-10	Medikit Co.,Ltd. authorizes a Buyback Plan.	CI
24-01-10	Tranche Update on Medikit Co.,Ltd.'s Equity Buyback Plan announced on December 5, 2023.	CI
24-01-08	Medikit Co.,Ltd.'s Equity Buyback announced on December 5, 2023, has closed with 2,000,000 shares, representing 11.91% for ¥4,776 million.	CI
23-12-05	Medikit Co.,Ltd. announces an Equity Buyback for 2,200,000 shares, representing 13.1% for ¥4,776 million.	CI
23-12-04	Medikit Co.,Ltd. authorizes a Buyback Plan.	CI
23-05-22	Nakajima Corporation agreed to acquire 5.46% stake in Medikit Co.,Ltd..	CI
23-05-15	Medikit Co.,Ltd. Reports Earnings Results for the Full Year Ended March 31, 2023	CI
22-12-22	Medikit Co.,Ltd. agreed to acquire remaining 90.03% stake in Bolt Medical Co., Ltd..	CI
22-07-05	Tranche Update on Medikit Co.,Ltd.'s Equity Buyback Plan announced on December 16, 2021.	CI
22-06-29	Medikit Co.,Ltd.'s Equity Buyback announced on December 16, 2021, has closed with 26,800 shares, representing 0.16% for ¥65.89 million.	CI
22-04-05	Tranche Update on Medikit Co.,Ltd.'s Equity Buyback Plan announced on December 16, 2021.	CI
22-01-07	Tranche Update on Medikit Co.,Ltd.'s Equity Buyback Plan announced on December 16, 2021.	CI
21-12-16	Medikit Co.,Ltd. announces an Equity Buyback for 144,000 shares, representing 0.86% for ¥400 million.	CI
21-12-15	Medikit Co.,Ltd. authorizes a Buyback Plan.	CI
21-09-30	United Managers Japan Withdraws Shareholder Proposal to Medikit	CI

Chart Medikit Co.,Ltd.

Duration

Period

7749: Dynamic Chart

Company Profile

MEDIKIT CO., LTD. is a Japan-based company involved in the development, manufacture and sale of medical equipment. Its major products consist of artificial diagnostic equipment, which includes indwelling needles that are used for artificial dialysis purposes; indwelling venous needles (anesthesia type), which are used for blood and fluid transfusion purposes, and angiography equipment, which includes introducers and angiographic catheters.

Employees

989

Sector

Medical Equipment, Supplies & Distribution

Calendar

02-05 - Q3 2025 Earnings Release (Projected)

More about the company